{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:30:40Z","timestamp":1793813440694,"version":"4.6.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ibroneuroreports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IBRO Neuroscience Reports"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ibneur.2026.07.017","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T06:22:11Z","timestamp":1785133331000},"page":"342-351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Therapeutic potential of edaravone and flurbiprofen in valproic acid-induced autism: Targeting oxidative stress and neuroinflammation"],"prefix":"10.1016","volume":"21","author":[{"given":"Anahita","family":"Hejazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razieh","family":"Hajisoltani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra","family":"Farbib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Sadr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Mehrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tourandokht","family":"Baluchnejadmojarad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraya","family":"Mehrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ibneur.2026.07.017_bib1","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/bs.3830100404","article-title":"Infantile autism and the schizophrenias","volume":"10","author":"Kanner","year":"1965","journal-title":"Behav. Sci."},{"issue":"3","key":"10.1016\/j.ibneur.2026.07.017_bib2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000398791","article-title":"Role of microglia in autism: recent advances","volume":"37","author":"Takano","year":"2015","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.ibneur.2026.07.017_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00787-012-0359-5","article-title":"Autism spectrum disorders","volume":"22","author":"Lauritsen","year":"2013","journal-title":"Eur. Child. Adolesc. Psychiatry"},{"issue":"2","key":"10.1016\/j.ibneur.2026.07.017_bib4","first-page":"95","article-title":"A shallow convolutional neural network for cerebral neoplasm detection from magnetic resonance imaging","volume":"4","author":"Sadr","year":"2024","journal-title":"Big Data Comput. Vis."},{"key":"10.1016\/j.ibneur.2026.07.017_bib5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.envint.2015.12.021","article-title":"Environmental factors in the development of autism spectrum disorders","volume":"88","author":"Sealey","year":"2016","journal-title":"Environ. Int."},{"issue":"5","key":"10.1016\/j.ibneur.2026.07.017_bib6","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3390\/ijerph13050504","article-title":"Epigenetic effect of environmental factors on autism spectrum disorders","volume":"13","author":"Kubota","year":"2016","journal-title":"Int. J. Environ. Res. Public. Health"},{"issue":"16","key":"10.1016\/j.ibneur.2026.07.017_bib7","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism","volume":"309","author":"Christensen","year":"2013","journal-title":"Jama"},{"key":"10.1016\/j.ibneur.2026.07.017_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.expneurol.2017.04.017","article-title":"The valproic acid-induced rodent model of autism","volume":"299","author":"Nicolini","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ibneur.2026.07.017_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111322","article-title":"Emerging mechanisms of valproic acid-induced neurotoxic events in autism and its implications for pharmacological treatment","volume":"137","author":"Taleb","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ibneur.2026.07.017_bib10","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1007\/s12035-020-01976-5","article-title":"Postmortem studies of neuroinflammation in autism spectrum disorder: a systematic review","volume":"57","author":"Liao","year":"2020","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.ibneur.2026.07.017_bib11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10856-025-06947-7","article-title":"Biomaterials for CNS disorders: a review of development from traditional methods to AI-assisted optimization","volume":"36","author":"Haramshahi","year":"2025","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.ibneur.2026.07.017_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2021.102179","article-title":"Effect of CSF1R inhibitor on glial cells population and remyelination in the cuprizone model","volume":"89","author":"Tahmasebi","year":"2021","journal-title":"Neuropeptides"},{"key":"10.1016\/j.ibneur.2026.07.017_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.psyneuen.2016.06.001","article-title":"Postnatal behavioral and inflammatory alterations in female pups prenatally exposed to valproic acid","volume":"72","author":"Kazlauskas","year":"2016","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.ibneur.2026.07.017_bib14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10072-025-08666-x","article-title":"A meta-analytic approach to identification of clinical biomarkers of hearing loss in cognitive impairment","volume":"47","author":"Moghadam","year":"2026","journal-title":"Neurol. Sci."},{"issue":"17","key":"10.1016\/j.ibneur.2026.07.017_bib15","doi-asserted-by":"crossref","first-page":"9803","DOI":"10.3390\/ijms23179803","article-title":"Lipid-based molecules on signaling pathways in autism spectrum disorder","volume":"23","author":"Yui","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ibneur.2026.07.017_bib16","article-title":"Assessment of a combination of plasma anti-histone autoantibodies and PLA2\/PE ratio as potential biomarkers to clinically predict autism spectrum disorders","volume":"12","author":"El-Ansary","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ibneur.2026.07.017_bib17","series-title":"A review on Flurbiprofen: Therapeutic challenges in Emerging Active Metabolizing Biphenyl","author":"Khullar","year":"2020"},{"key":"10.1016\/j.ibneur.2026.07.017_bib18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2147\/JIR.S278514","article-title":"Overview on the discovery and development of anti-inflammatory drugs: should the focus be on synthesis or degradation of PGE2?","author":"Mahesh","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.ibneur.2026.07.017_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103477","article-title":"Flurbiprofen-chalcone hybrid Mannich base derivatives as balanced multifunctional agents against Alzheimer\u2019s disease: Design, synthesis and biological evaluation","volume":"94","author":"Tian","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"9","key":"10.1016\/j.ibneur.2026.07.017_bib20","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.3390\/ijms23095202","article-title":"Obesity as a risk factor for dementia and Alzheimer\u2019s disease: the role of leptin","volume":"23","author":"Flores-Cordero","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ibneur.2026.07.017_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41398-020-01135-3","article-title":"Oxidative stress marker aberrations in children with autism spectrum disorder: a systematic review and meta-analysis of 87 studies (N= 9109)","volume":"11","author":"Chen","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.ibneur.2026.07.017_bib22","article-title":"vitro modulation of endogenous antioxidant enzyme activities and oxidative stress in autism lymphoblastoid cell line (ALCL) by stingless bee honey treatment","volume":"2020","author":"Nayan","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ibneur.2026.07.017_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2019.114689","article-title":"Edaravone presents antidepressant-like activity in corticosterone model of depression in mice with possible role of Fkbp5, Comt, Adora1 and Slc6a15 genes","volume":"380","author":"Herbet","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.ibneur.2026.07.017_bib24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.seizure.2008.06.012","article-title":"Neuroprotective effects of edaravone, a free radical scavenger, on the rat hippocampus after pilocarpine-induced status epilepticus","volume":"18","author":"Kamida","year":"2009","journal-title":"Seizure"},{"issue":"1","key":"10.1016\/j.ibneur.2026.07.017_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0301-0082(98)00075-6","article-title":"Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action","volume":"58","author":"L\u00f6scher","year":"1999","journal-title":"Progress. Neurobiol."},{"issue":"8","key":"10.1016\/j.ibneur.2026.07.017_bib26","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/jps.2600770805","article-title":"Stereoselective pharmacokinetics of flurbiprofen in humans and rats","volume":"77","author":"Jamali","year":"1988","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ibneur.2026.07.017_bib27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1042-3680(18)30322-X","article-title":"Acute therapeutic interventions: Free radical scavengers and antioxidants","volume":"8","author":"Hall","year":"1997","journal-title":"Neurosurg. Clin. North. Am."},{"issue":"1","key":"10.1016\/j.ibneur.2026.07.017_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1527-3458.2006.00009.x","article-title":"Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury","volume":"12","author":"Yoshida","year":"2006","journal-title":"CNS Drug. Rev."},{"key":"10.1016\/j.ibneur.2026.07.017_bib29","doi-asserted-by":"crossref","unstructured":"Dang, R., Wang, M., Li, X., Wang, H., Liu, L., Wu, Q., , 2022. Edaravone ameliorates depressive and anxiety-like behaviors via Sirt1\/Nrf2\/HO-1\/Gpx4 pathway. 2022;19(1):41..","DOI":"10.1186\/s12974-022-02400-6"},{"issue":"16","key":"10.1016\/j.ibneur.2026.07.017_bib30","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1073\/pnas.1422998112","article-title":"Edaravone alleviates Alzheimer's disease-type pathologies and cognitive deficits","volume":"112","author":"Jiao","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.ibneur.2026.07.017_bib31","doi-asserted-by":"crossref","first-page":"514","DOI":"10.5114\/aoms.2019.89849","article-title":"Edaravone attenuates neuronal apoptosis in hippocampus of rat traumatic brain injury model via activation of BDNF\/TrkB signaling pathway","volume":"17","author":"Ding","year":"2021","journal-title":"Archives Med. Sci. AMS"},{"key":"10.1016\/j.ibneur.2026.07.017_bib32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12868-014-0125-3","article-title":"Anti-inflammatory effects of Edaravone and Scutellarin in activated microglia in experimentally induced ischemia injury in rats and in BV-2 microglia","volume":"15","author":"Yuan","year":"2014","journal-title":"BMC Neurosci."},{"issue":"10","key":"10.1016\/j.ibneur.2026.07.017_bib33","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1089\/neu.2011.1939","article-title":"Free-radical scavenger edaravone treatment confers neuroprotection against traumatic brain injury in rats","volume":"28","author":"Wang","year":"2011","journal-title":"J. Neurotrauma"},{"issue":"2","key":"10.1016\/j.ibneur.2026.07.017_bib34","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0361-9230(01)00510-X","article-title":"Iron and neurodegenerative disorders","volume":"55","author":"Thompson","year":"2001","journal-title":"Brain Res. Bull."},{"issue":"9","key":"10.1016\/j.ibneur.2026.07.017_bib35","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/j.bmc.2013.03.005","article-title":"Design, synthesis and evaluation of tacrine-flurbiprofen-nitrate trihybrids as novel anti-Alzheimer's disease agents","volume":"21","author":"Chen","year":"2013","journal-title":"Bioorg. Med. Chem."},{"issue":"4","key":"10.1016\/j.ibneur.2026.07.017_bib36","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20171562","article-title":"Flurbiprofen axetil attenuates cerebral ischemia\/reperfusion injury by reducing inflammation in a rat model of transient global cerebral ischemia\/reperfusion","volume":"38","author":"Wu","year":"2018","journal-title":"Biosci. Rep."},{"issue":"3","key":"10.1016\/j.ibneur.2026.07.017_bib37","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000375489","article-title":"Differential Local Connectivity and Neuroinflammation Profiles in the Medial Prefrontal Cortex and Hippocampus in the Valproic Acid Rat Model of Autism","volume":"37","author":"Codagnone","year":"2015","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.ibneur.2026.07.017_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108654","article-title":"Akt \/ GSK3\u03b2 \/ Nrf2 \/ HO-1 pathway activation by flurbiprofen protects the hippocampal neurons in a rat model of glutamate excitotoxicity","volume":"196","author":"Farhat","year":"2021","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.ibneur.2026.07.017_bib39","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1474-4422(08)70090-5","article-title":"Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial","volume":"7","author":"Wilcock","year":"2008","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.ibneur.2026.07.017_bib40","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/01.RES.0000115557.25127.8D","article-title":"Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor","volume":"94","author":"Wassmann","year":"2004","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.ibneur.2026.07.017_bib41","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.bbrc.2011.05.095","article-title":"The Akt\/GSK-3\u03b2 pathway mediates flurbiprofen-induced neuroprotection against focal cerebral ischemia\/reperfusion injury in rats","volume":"409","author":"Sun","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.ibneur.2026.07.017_bib42","first-page":"59","article-title":"Role of serum albumin as a nanoparticulate carrier for nose-to-brain delivery of R-flurbiprofen: implications for the treatment of Alzheimer's disease","volume":"70","author":"Wong","year":"2018"},{"key":"10.1016\/j.ibneur.2026.07.017_bib43","doi-asserted-by":"crossref","unstructured":"Tahmasebi, F., Barati, S., 2023. The Role of Microglial Depletion Approaches in Pathological Condition of CNS. 2023;43(6):2459-2471..","DOI":"10.1007\/s10571-023-01326-8"},{"issue":"1","key":"10.1016\/j.ibneur.2026.07.017_bib44","first-page":"4","article-title":"Recent advances in the relationship between obesity, inflammation, and insulin resistance","volume":"17","author":"Bastard","year":"2006","journal-title":"Eur. Cytokine Netw."},{"issue":"6","key":"10.1016\/j.ibneur.2026.07.017_bib45","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.bbadis.2012.01.011","article-title":"Brain IL-6 elevation causes neuronal circuitry imbalances and mediates autism-like behaviors","volume":"1822","author":"Wei","year":"2012","journal-title":"Biochim. Et. Biophys. Acta"},{"key":"10.1016\/j.ibneur.2026.07.017_bib46","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbi.2022.09.002","article-title":"Transfer of neuron-derived \u03b1-synuclein to astrocytes induces neuroinflammation and blood-brain barrier damage after methamphetamine exposure: Involving the regulation of nuclear receptor-associated protein 1","volume":"106","author":"Huang","year":"2022","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.ibneur.2026.07.017_bib47","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cyto.2014.10.027","article-title":"Interplay between pro-inflammatory cytokines and brain oxidative stress biomarkers: evidence of parallels between butyl paraben intoxication and the valproic acid brain physiopathology in autism rat model","volume":"71","author":"Hegazy","year":"2015","journal-title":"Cytokine"}],"container-title":["IBRO Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242126001181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242126001181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T16:40:25Z","timestamp":1793810425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667242126001181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":47,"alternative-id":["S2667242126001181"],"URL":"https:\/\/doi.org\/10.1016\/j.ibneur.2026.07.017","relation":{},"ISSN":["2667-2421"],"issn-type":[{"value":"2667-2421","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of edaravone and flurbiprofen in valproic acid-induced autism: Targeting oxidative stress and neuroinflammation","name":"articletitle","label":"Article Title"},{"value":"IBRO Neuroscience Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ibneur.2026.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Brain Research Organization.","name":"copyright","label":"Copyright"}]}}